Top

Published in:

Open Access 01-10-2018 | Original Scientific Report

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease

Authors: Katrin Schwameis, Milena Nikolic, Deivis G. Morales Castellano, Ariane Steindl, Sarah Macheck, Ivan Kristo, Barbara Zörner, Sebastian F. Schoppmann

Published in: World Journal of Surgery | Issue 10/2018

Abstract

Background

Magnetic sphincter augmentation (MSA) is a modern treatment option for gastroesophageal reflux disease (GERD); however, laparoscopic fundoplication remains the gold standard. The aim of the study was to evaluate outcomes of MSA patients at a reflux center.

Methods

A retrospective review was performed of all patients that underwent MSA between March 2012 and November 2017. Out of 110 patients, 68 with a follow-up >3 months were included. Postoperative gastrointestinal symptoms, proton pump inhibitor (PPI) intake, GERD-Health-related Quality of Life (GERD-HRQL) and alimentary satisfaction (AS) were assessed. Postoperative esophageal functioning tests were performed in 50% of patients.

Results

Sixty-eight patients underwent MSA; hiatal repair was performed in 31 cases. The median OR time was 27 min, and no intraoperative complications occurred. The median follow-up was 13 months (IQR 4.2–45). Endoscopic dilatation was performed in 2 patients (3%) and device removal in another 2 cases. The postoperative GERD-HRQL score was significantly reduced (3 vs. 24; p < 0.001) and the median AS was 8/10. Preoperative experienced heartburn, regurgitations and dysphagia were eliminated in 92, 96 and 100%. Postoperative new-onset difficulties swallowing with solids only were reported to occur occasionally by 16% and rarely by 21% of patients. Satisfaction with heartburn relief was 95%, and the overall outcome was rated excellent/good in 89%. PPI dependency was eliminated in 87%. The median total percentage pH < 4 and number of reflux episodes were significantly reduced. Postoperative pH results were negative or slightly above the norm in 79% and 12%, respectively.

Conclusion

Sphincter augmentation results in significantly reduced reflux symptoms, increased GERD-specific Quality of Life and excellent alimentary satisfaction with low perioperative morbidity. This procedure should be considered an excellent alternative to fundoplication in the treatment of GERD.

Reynolds JL, Zehetner J, Nieh A et al (2016) Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus laparoscopic Nissen fundoplication for the treatment of GERD. Surg Endosc 30:3225–3230CrossRefPubMed

Bonavina L, Saino GI, Bona D et al (2008) Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg 12:2133–2140CrossRefPubMed

Reynolds JL, Zehetner J, Wu P et al (2015) Laparoscopic magnetic sphincter augmentation vs laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg 221:123–128CrossRefPubMed

Rona KA, Reynolds J, Schwameis K et al (2016) Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc 31:2096–2102CrossRefPubMed

Skubleny D, Switzer NJ, Dang J et al (2017) LINX(R) magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surg Endosc 31:3078–3084CrossRefPubMed

Czosnyka NM, Buckley FP, Doggett SL et al (2017) Outcomes of magnetic sphincter augmentation: a community hospital perspective. Am J Surg 213:1019–1023CrossRefPubMed

Ganz RA, Edmundowicz SA, Taiganides PA et al (2016) Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol 14:671–677CrossRefPubMed

Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA (2015) Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech A 25:787–792CrossRefPubMedPubMedCentral

DeMeester TR (2017) Surgical options for the treatment of gastroesophageal reflux disease. Gastroenterol Hepatol (N Y) 13:128–129

10.

Greene CL, Worrell SG, DeMeester TR (2015) Rat reflux model of esophageal cancer and its implication in human disease. Ann Surg 262:910–924CrossRefPubMed

11.

Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 23:3–9CrossRefPubMedPubMedCentral

12.

Schwameis K, Zehetner J, Rona K et al (2017) Post-nissen dysphagia and bloating syndrome: outcomes after conversion to Toupet fundoplication. J Gastrointest Surg 21:441–445CrossRefPubMed

13.

Bonavina L, Saino G, Lipham JC, Demeester TR (2013) LINX((R)) Reflux management system in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol 6:261–268CrossRefPubMedPubMedCentral

14.

Skubleny D, Switzer NJ, Dang J et al (2016) LINX(R) magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis. Surg Endosc 31(8):3078–3084CrossRefPubMed

15.

Greene CL, DeMeester SR, Augustin F et al (2014) Long-term quality of life and alimentary satisfaction after esophagectomy with colon interposition. Ann Thorac Surg 98:1713–1719 (discussion 1719–20) CrossRefPubMed

16.

Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed

17.

Velanovich V, Karmy-Jones R (1998) Measuring gastroesophageal reflux disease: relationship between the health-related quality of life score and physiologic parameters. Am Surg 64:649–653PubMed

18.

Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130–134CrossRefPubMed

19.

Saeed ZA, Winchester CB, Ferro PS et al (1995) Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc 41:189–195CrossRefPubMed

20.

Ayazi S, Lipham JC, Portale G et al (2009) Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 7:60–67CrossRefPubMed

21.

Bonavina L, DeMeester T, Fockens P et al (2010) Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 252:857–862CrossRefPubMed

22.

Lipham JC, DeMeester TR, Ganz RA et al (2012) The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 26:2944–2949CrossRefPubMed

23.

Louie BE, Farivar AS, Shultz D et al (2014) Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease. Ann Thorac Surg 98:498–504 (discussion 504–5) CrossRefPubMed

24.

Bonavina L, Saino G, Bona D, Sironi A, Lazzari V (2013) One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg 217:577–585CrossRefPubMed

25.

Warren HF, Reynolds JL, Lipham JC et al (2016) Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 30:3289–3296CrossRefPubMed

26.

Rona KA, Reynolds J, Schwameis K et al (2017) Efficacy of magnetic sphincter augmentation in patients with large hiatal hernias. Surg Endosc 31:2096–2102CrossRefPubMed

27.

Buckley FP 3rd, Bell RCW, Freeman K, Doggett S, Heidrick R (2017) Favorable results from a prospective evaluation of 200 patients with large hiatal hernias undergoing LINX magnetic sphincter augmentation. Surg Endosc 32(4):1762–1768CrossRefPubMedPubMedCentral

28.

Mittal RK (1993) The crural diaphragm, an external lower esophageal sphincter: a definitive study. Gastroenterology 105:1565–1567CrossRefPubMed

29.

Pandolfino JE, Kim H, Ghosh SK et al (2007) High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol 102:1056–1063CrossRefPubMed

30.

Woodward ER, Thomas HF, McAlhany JC (1971) Comparison of crural repair and Nissen fundoplication in the treatment of esophageal hiatus hernia with peptic esophagitis. Ann Surg 173:782–792CrossRefPubMedPubMedCentral

31.

Lund RJ, Wetcher GJ, Raiser F et al (1997) Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg 1:301–308 (discussion 308) CrossRefPubMed

Title: Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease
Authors: Katrin Schwameis
Milena Nikolic
Deivis G. Morales Castellano
Ariane Steindl
Sarah Macheck
Ivan Kristo
Barbara Zörner
Sebastian F. Schoppmann
Publication date: 01-10-2018
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 10/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-018-4608-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2018

Gallstone Pancreatitis and Choledocholithiasis: Using Imaging and Laboratory Trends to Predict the Likelihood of Persistent Stones at Cholangiography

Clinical Impact of Preoperative Sarcopenia on the Postoperative Outcomes After Pancreas Transplantation

VATS Partial Pleurectomy Versus VATS Pleural Abrasion: Significant Reduction in Pneumothorax Recurrence Rates After Pleurectomy

Analysis of Early and Long-Term Oncologic Outcomes After Converted Laparoscopic Resection Compared to Primary Open Surgery for Rectal Cancer

Surgical Indication for Advanced Intrahepatic Cholangiocarcinoma According to the Optimal Preoperative Carbohydrate Antigen 19-9 Cutoff Value

Effectiveness of Pelvic Floor Rehabilitation for Bowel Dysfunction After Intersphincteric Resection for Lower Rectal Cancer